Study guide

10.1 Postpartum Hemorrhage: Definition, Risk Stratification, 4 Ts, QBL & Pharmacotherapy

NCC Inpatient Obstetric Nursing RNC-OB

Track your progress as you read

Finished sections get a check mark.

1 Chapter 0: Introduction & How to Use This Guide

0.1 About the RNC-OB Credential & Exam Blueprint 0.2 How to Use This Study Guide & Clinical Learning Methodology

2 Chapter 1: Pregnancy Complications — Maternal Medical Conditions

1.1 Hypertensive Disorders of Pregnancy 1.2 HELLP Syndrome & Hepatic Disorders of Pregnancy 1.3 Diabetes Mellitus in Pregnancy 1.4 Maternal Cardiac and Respiratory Disorders 1.5 Infectious Diseases in Inpatient Obstetrics 1.6 Hematologic, Endocrine, Connective Tissue & Other Systemic Disorders

3 Chapter 2: Pregnancy Complications — Preterm Labor, Multiple Gestation, Placental & Fetal Disorders

2.1 Psychosocial Disorders, Substance Use & Environmental Exposures 2.2 Preterm Labor: Assessment, Tocolysis & Neuroprotection 2.3 Multiple Gestation: Placentation, Chorionicity & Complications 2.4 Placental Disorders: Previa, Abruption, Vasa Previa & PAS 2.5 Fetal Growth Disorders & Amniotic Fluid Complications

4 Chapter 3: Antenatal Fetal Assessment & Surveillance

3.1 Antenatal Testing Methods & Indications for Fetal Surveillance 3.2 Nonstress Test (NST), Contraction Stress Test (CST) & Biophysical Profile (BPP) 3.3 Diagnostic Prenatal Procedures (Amniocentesis, CVS, PUBS, cfDNA & Ultrasound) 3.4 Fetal Oxygenation Physiology & Acid-Base Regulation 3.5 Umbilical Cord Blood Gas Collection & Clinical Interpretation

5 Chapter 4: Fetal Assessment & Electronic Fetal Monitoring (EFM)

4.1 NICHD Electronic Fetal Monitoring Terminology & Baseline Features 4.2 FHR Decelerations, Acceleration Patterns & Uterine Activity 4.3 The NICHD Three-Tier Fetal Heart Rate Classification System 4.4 Intrauterine Resuscitation & Clinical Action Protocols 4.5 Fetal Arrhythmias, Dysrhythmias & Artifact Differentiation

6 Chapter 5: Labor & Birth Physiology — Mechanics, Cardinal Movements, Stages & Support

5.1 Physiology of Labor & Uterine Mechanics 5.2 Pelvic Anatomy, Fetal Lie, Presentation & Cardinal Movements of Labor 5.3 Stages of Labor, Cervical Dilatation Dynamics & Progression Guidelines 5.4 Intrapartum Admission Assessment, Obstetric Triage & Membrane Rupture Evaluation 5.5 Labor Support, Non-Pharmacologic Pain Management & Physiologic Birth Practices

7 Chapter 6: Labor & Birth Interventions — Cervical Ripening, Induction, Pain Management & Anesthesia

6.1 Bishop Scoring, Pre-Induction Cervical Ripening & Mechanical Methods 6.2 Oxytocin Administration, Titration Protocols & Uterine Tachysystole Management 6.3 Nonpharmacologic Comfort & Labor Pain Management Strategies 6.4 Systemic Opioid Analgesia & Inhaled Nitrous Oxide 6.5 Neuraxial Analgesia, Spinal/Epidural Complications & General Anesthesia

8 Chapter 7: Labor & Birth — Operative Deliveries, TOLAC/VBAC & Special Intrapartum Procedures

7.1 External Cephalic Version (ECV) & Malpresentation Management 7.2 Operative Vaginal Delivery: Vacuum Extraction & Forceps-Assisted Birth 7.3 Cesarean Delivery: Surgical Indications, Intraoperative Management & PACU Recovery 7.4 Trial of Labor After Cesarean (TOLAC) & Vaginal Birth After Cesarean (VBAC) 7.5 Special Intrapartum Procedures: Amniotomy, Amnioinfusion, Cervical Ripening & Labor Augmentation

9 Chapter 8: Obstetric Emergencies & Critical Care

8.1 Shoulder Dystocia Management & HELPERR Protocol 8.2 Umbilical Cord Prolapse & Feto-Vascular Emergencies 8.3 Uterine Rupture & Acute Uterine Inversion 8.4 Amniotic Fluid Embolism (Anaphylactoid Syndrome of Pregnancy) 8.5 Intraamniotic Infection (Chorioamnionitis) & Maternal Sepsis

10 Chapter 9: Postpartum Physiology & Immediate Recovery Care

9.1 Postpartum Physiologic Changes & Maternal Systemic Adaptations 9.2 Fourth Stage of Labor & Immediate Recovery Care 9.3 Routine Postpartum Nursing Assessment & Clinical Care (BUBBLE-HE) 9.4 Rh Isoimmunization, Alloimmunization & Postpartum Immunizations 9.5 Postpartum Discharge Teaching, Warning Signs & Maternal Safety

11 Chapter 10: Postpartum Adaptation, Hemorrhage & Clinical Complications

10.1 Postpartum Hemorrhage: Definition, Risk Stratification, 4 Ts, QBL & Pharmacotherapy 10.2 Postpartum Infections: Endometritis, Wound Infections, Sepsis & Postpartum Pyrexia 10.3 Thromboembolic Disorders: DVT, Pulmonary Embolism & Septic Pelvic Thrombophlebitis 10.4 Perinatal Mood & Anxiety Disorders: Postpartum Blues, PPD, Anxiety & Postpartum Psychosis 10.5 Lactation Physiology, Breastfeeding Complications, Engorgement & Medication Safety

12 Chapter 11: Newborn Care, Transition & Clinical Assessment

11.1 Neonatal Physiologic Transition & Cardiorespiratory Adaptation 11.2 Immediate Newborn Care, Apgar Scoring & Delivery Room Stabilization 11.3 Newborn Thermoregulation & Pathophysiology of Cold Stress 11.4 Gestational Age & Neonatal Growth Assessment 11.5 Comprehensive Newborn Head-to-Toe Examination & Normal Variants

13 Chapter 12: Newborn Complications, Resuscitation & High-Acuity Management

12.1 Neonatal Resuscitation Program (NRP 8th Edition) & Delivery Room Resuscitation 12.2 Neonatal Glucose Homeostasis, Hypoglycemia Screening & Clinical Management 12.3 Neonatal Hyperbilirubinemia, Bilirubin Metabolism & Phototherapy Protocols 12.4 Neonatal Respiratory Distress: TTN, RDS, Meconium Aspiration & Persistent Pulmonary Hypertension (PPHN) 12.5 Neonatal Sepsis, Congenital Infections & Neonatal Abstinence Syndrome (NAS/NOWS)

14 Chapter 13: Professional Practice, Legal-Ethical Frameworks, Patient Safety & Quality Improvement

13.1 Legal Aspects of Perinatal Nursing & High-Risk Documentation Standards 13.2 Ethical Principles in Perinatal Care & Maternal-Fetal Conflicts 13.3 Quality Improvement, Perinatal Safety Initiatives & AIM Bundles 13.4 Patient Safety Culture, Team Communication & Clinical Escalation 13.5 Evidence-Based Practice, Research Utilization & Perinatal Guidelines

10.1 Postpartum Hemorrhage: Definition, Risk Stratification, 4 Ts, QBL & Pharmacotherapy

Key Takeaways Explain This Topic AI

Postpartum Hemorrhage (PPH) is defined as cumulative blood loss ≥1,000 mL or blood loss accompanied by signs or symptoms of hypovolemia within 24 hours of birth regardless of delivery route; Quantitative Blood Loss (QBL) gravimetric measurement (1 g wet weight difference = 1 mL blood loss) is the universal standard replacing visual estimation.

The underlying etiology is systematically categorized by the '4 Ts': Tone (uterine atony, 70–80%), Trauma (lacerations/hematomas, 15–20%), Tissue (retained placenta/membranes/PAS, 5–10%), and Thrombin (coagulopathies/DIC/abruption, 1–2%).

First-line uterotonic therapy is Oxytocin (10–40 units/1,000 mL IV infusion or 10 units IM; never rapid undiluted IV push), followed by second-line agents: Methylergonovine (0.2 mg IM; strictly contraindicated in hypertension), Carboprost tromethamine (250 mcg IM; strictly contraindicated in active asthma), and Misoprostol (800–1,000 mcg PR or 800 mcg SL).

Tranexamic Acid (TXA; 1 g IV over 10 minutes) must be administered within 3 hours of birth for refractory PPH; mechanical tamponade (intrauterine Bakri balloon, low-level vacuum devices) and surgical interventions (B-Lynch brace sutures, arterial ligation, hysterectomy) are deployed before irreversible coagulopathy develops.

Massive Transfusion Protocol (MTP) is activated for blood loss >1,500 mL or vital sign instability (Obstetric Shock Index ≥0.9–1.0), delivering a balanced 1:1:1 ratio of PRBCs, FFP, and Platelets, alongside serial fibrinogen monitoring to maintain plasma fibrinogen ≥200 mg/dL using Cryoprecipitate.

Last updated: August 2026

Clinical Foundations, Redefinition & Hemodynamic Realities of PPH

Postpartum hemorrhage (PPH) remains one of the leading global causes of maternal mortality and severe maternal morbidity (SMM). In high-resource inpatient obstetric units, maternal mortality from hemorrhage is largely preventable through standardized clinical bundles, early recognition of occult blood loss, objective quantification, and aggressive, protocolized multidisciplinary intervention.

Historically, obstetric definitions differentiated between vaginal delivery (blood loss >500 mL) and cesarean delivery (blood loss >1,000 mL). However, clinical data demonstrated that average blood loss during an uncomplicated cesarean delivery frequently reaches 800–1,000 mL without hemodynamic compromise, while relying on a 500 mL threshold for vaginal birth led to either over-treatment or delayed recognition of true maternal decompensation. +---------------------------------------------------------------------------------------------------+

  • | CONTEMPORARY STANDARDIZED DEFINITION OF PPH |
  • | (ACOG Practice Bulletin 183 / AWHONN / AIM) |
  • +---------------------------------------------------------------------------------------------------+
  • │
  • ▼
  • "Cumulative blood loss of 1,000 mL OR GREATER, OR blood loss accompanied by signs or symptoms
  • of hypovolemia (hypotension, tachycardia, tachypnea, oliguria, pallor, diaphoresis, altered
  • mental status) within 24 hours of the birth process (regardless of delivery route)."
  • │
  • ┌─────────────────────────────┴─────────────────────────────┐
  • ▼ ▼
  • [ PRIMARY / EARLY PPH ] [ SECONDARY / LATE PPH ]
  • Occurs within first 24 hours post-birth • Occurs 24 hours to 12 weeks postpartum
  • Highest incidence (70-80% uterine atony) • Retained placental fragments / Cotyledons
  • High velocity, sudden catastrophic shock • Subinvolution of placental implantation site
  • Rapidly requires acute pharmacologic / mechanical care • Postpartum endometritis / Pelvic infection
  • Maternal Hemodynamics & The Fallacy of Delayed Vital Sign Changes

During normal singleton pregnancy, maternal circulating plasma volume expands by 40% to 50% (approximately 1,200 to 1,500 mL), accompanied by a 20% to 30% expansion in red blood cell mass. This profound physiologic hypervolemia serves as a protective biological buffer against peripartum blood loss. However, this compensatory reserve creates a treacherous clinical pitfall for the inpatient obstetric nurse:

Compensated Stage (Blood Loss 500–1,000 mL; 10–15% blood volume): Blood pressure remains normal or slightly elevated due to sympathetically mediated peripheral vasoconstriction; maternal heart rate may exhibit mild, subtle resting tachycardia (80–100 bpm); pulse pressure narrows.

Mild Shock / Early Decompensation (Blood Loss 1,000–1,500 mL; 15–25% blood volume): Postural hypotension, diaphoresis, cutaneous pallor, cool extremities, mild tachycardia (100–120 bpm), and tachypnea (respiratory rate 20–24 bpm). Systolic blood pressure may still register within normal limits (e.g., 100/60 mmHg).

Moderate to Severe Shock (Blood Loss 1,500–2,000+ mL; 25–40%+ blood volume): Precipitous hypotension (systolic BP <80–90 mmHg), severe tachycardia (>120–140 bpm), extreme pallor, cold/clammy skin, confusion, air hunger, and progressive oliguria (<30 mL/hr) progressing to anuria.

CRITICAL CLINICAL PEARL: In obstetric patients, hypotension is a late, catastrophic sign of massive blood loss . By the time a previously healthy postpartum patient exhibits classic hypotension (systolic BP <90 mmHg), she has lost at least 30% to 40% (1,500–2,000 mL) of her total vascular volume . Nurses must never wait for blood pressure to drop before declaring an obstetric hemorrhage and initiating active resuscitation.

Quantitative Blood Loss (QBL) vs. Visual Estimation (EBL)

Visual estimation of blood loss (EBL) is notoriously inaccurate. Extensive clinical trials demonstrate that obstetricians and labor nurses underestimate blood loss by 33% to 50% when bleeding is heavy (>1,000 mL) and overestimate blood loss when volumes are minimal. Underestimation breeds cognitive complacency, causing catastrophic delays in uterotonic administration and blood product transfusion.

Quantitative Blood Loss (QBL) is the direct, objective measurement of blood loss using standardized gravimetric (weighing) and volumetric techniques. QBL initiation must begin immediately upon delivery of the newborn: +---------------------------------------------------------------------------------------------------+

  • | QUANTITATIVE BLOOD LOSS (QBL) WORKFLOW |
  • +---------------------------------------------------------------------------------------------------+
  • [ STEP 1: DELIVERY OF NEWBORN ]
  • Place calibrated volumetric collection drape beneath maternal buttocks (vaginal birth),

or position dedicated suction canisters on surgical field (cesarean birth).

• Suction amniotic fluid immediately post-rupture/delivery into a separate primary canister

or record total amniotic fluid volume prior to placental expulsion.

  • │
  • ▼
  • [ STEP 2: PLACENTAL EXPULSION & ONGOING RECOVERY ]
  • Collect all ongoing blood loss into the calibrated drape or dedicated surgical suction canister.

• Calculate net suction volume: [Total Fluid in Suction Canister] minus [Estimated Amniotic Fluid

and Irrigation Volume].

  • │
  • ▼
  • [ STEP 3: GRAVIMETRIC WEIGHING OF ALL BLOOD-SOAKED MATERIALS ]
  • Weigh all blood-saturated sponges, laps, chux, peri-pads, and drapes on a calibrated gram scale.
  • Standard conversion formula:
  • 1 gram (g) of wet weight difference = 1 milliliter (mL) of blood loss
  • Calculation: [Total Wet Weight of Saturated Items (g)] minus [Known Dry Weight of Items (g)]
  • │
  • ▼
  • [ STEP 4: TOTAL CUMULATIVE QBL CALCULATION & CONTINUOUS REPORTING ]
  • Total QBL (mL) = [Net Calibrated Drape / Suction Volume (mL)] + [Net Gravimetric Scale Weight (mL)]
  • Announce cumulative QBL to the multidisciplinary team at regular intervals and upon reaching

key clinical triggers (500 mL, 1,000 mL, 1,500 mL).

Standard Dry Weight Reference Matrix for Inpatient Obstetric Units

Item / Supply Type Standard Dry Weight Gravimetric QBL Calculation Rule

Standard Laparotomy Sponge (18x18, 5-pack) ~100 g per pack (20 g each) (Wet weight of 5 laps in g) - 100 g = Blood Loss (mL)

Ray-Tec 4x4 Sponge (10-pack) ~40 g per pack (4 g each) (Wet weight of 10 sponges in g) - 40 g = Blood Loss (mL)

  • Heavy Obstetric Underpad (Chux) ~45–50 g (Wet weight in g) - 50 g = Blood Loss (mL)
  • Postpartum Perineal Pad (Standard) ~12–15 g (Wet weight in g) - 15 g = Blood Loss (mL)
  • Postpartum Maternity Maximum Pad ~25–30 g (Wet weight in g) - 30 g = Blood Loss (mL)

Under-Buttocks Drape with Calibrated Pouch Visual direct reading Read fluid level in graduated pouch (subtract clear amniotic fluid)

The "4 Ts" Etiologic Framework

Uterine hemostasis following placental separation depends primarily on physiologic myometrial contraction . The unique architecture of interlacing, criss-cross ("figure-of-eight") smooth muscle bundles in the myometrium contract tightly, mechanically constricting and kinking the open, severed spiral arteries that once supplied maternal blood to the intervillous space at a rate of 600 to 800 mL/min (accounting for 15% of maternal cardiac output). When myometrial contraction fails or local/systemic pathology interferes, catastrophic hemorrhage ensues. The nurse must rapidly assess the patient across the 4 Ts : +---------------------------------------------------------------------------------------------------+

  • | THE "4 Ts" ETIOLOGIC MATRIX OF PPH |
  • +---------------------------------------------------------------------------------------------------+
  • ┌───────────────────────────────────┬───────────────────────────────────┐
  • │ 1. TONE: UTERINE ATONY (70-80%) │ 2. TRAUMA: LACERATIONS (15-20%) │
  • ├───────────────────────────────────┼───────────────────────────────────┤
  • │ • Overdistended uterus (poly, │ • Cervical / Vaginal lacerations │
  • │ macrosomia, multiples) │ • 3rd / 4th degree perineal tears │
  • │ • Prolonged / precipitous labor │ • Expanding vulvar/pelvic hematoma│
  • │ • High parity / Chorioamnionitis │ • Uterine inversion / Uterine tear│
  • │ • Magnesium sulfate / Tocolytics │ • Fundus: FIRM; Bleeding: BRIGHT │
  • │ • Bladder distention │ RED, steady trickle or pulsatile│
  • └───────────────────────────────────┴───────────────────────────────────┘
  • ┌───────────────────────────────────┬───────────────────────────────────┐
  • │ 3. TISSUE: RETAINED (5-10%) │ 4. THROMBIN: COAGULOPATHY (1-2%)│
  • ├───────────────────────────────────┼───────────────────────────────────┤
  • │ • Retained placental cotyledons │ • Disseminated Intravascular │
  • │ or succenturiate lobe │ Coagulation (DIC) │
  • │ • Retained blood clots / membranes│ • Severe Placental Abruption │
  • │ • Placenta Accreta Spectrum (PAS) │ • Amniotic Fluid Embolism (AFE) │
  • │ • Fundus: Boggy / Subinvoluted │ • Severe Preeclampsia / HELLP │
  • │ • Incomplete placenta on exam │ • Pre-existing von Willebrand / ITP│
  • └───────────────────────────────────┴───────────────────────────────────┘
  • Clinical Differentiation of the 4 Ts

Tone (Uterine Atony): The uterine fundus is soft, boggy, poorly contracted, and positioned above the umbilicus or displaced laterally (often to the right due to a full urinary bladder). Expressing fundal pressure produces a gush of dark red blood and large clots. Initial action: Immediate vigorous fundal massage and straight catheterization to empty the bladder.

Trauma (Lacerations & Hematomas): The uterine fundus is firm, midline, and well-contracted , yet there is continuous, steady trickling, seeping, or active pulsatile pumping of bright red blood from the introitus. Hematomas present with severe, intractable, out-of-proportion pelvic, rectal, or perineal pressure/pain, fullness, and maternal tachycardia, often with minimal external bleeding if the hematoma is retroperitoneal or infra-levator.

Tissue (Retained Products of Conception): Incomplete placental delivery, missing cotyledons, sheared vessel branches extending to membrane margins (indicating an undelivered succenturiate lobe), or abnormal placental adherence (Placenta Accreta, Increta, Percreta). The uterus remains boggy and fails to respond fully to uterotonics until the uterine cavity is manually or surgically explored and evacuated.

Thrombin (Systemic Coagulopathy): Oozing of non-clotting, watery blood from the uterus, IV puncture sites, surgical incisions, urinary catheter, or gums. Associated with severe placental abruption, dead fetus syndrome, massive hemorrhage-induced dilutional coagulopathy, septic shock, HELLP syndrome, or amniotic fluid embolism (AFE).

Stepwise Pharmacotherapy for Postpartum Hemorrhage

Pharmacologic intervention must occur rapidly in a structured, sequential escalation. Every inpatient obstetric nurse must master the dosing, administration route, side-effect profile, mechanism, and absolute contraindications for each uterotonic agent. +---------------------------------------------------------------------------------------------------+

  • | STEPWISE UTEROTONIC & PHARMACOLOGIC ESCALATION |
  • +---------------------------------------------------------------------------------------------------+
  • [ 1. OXYTOCIN (Pitocin) - FIRST-LINE DRUG FOR ALL PPH ]
  • Dose: 10-40 units in 1,000 mL LR/NS IV infusion (titrated rapidly: 250-500 mL/hr),

OR 10 units IM if no IV access.

• Mechanism: Binds oxytocin receptors on myometrial cells -> rhythmic upper segment contractions.

• Contraindications: NONE for PPH. WARNING: NEVER give undiluted IV push (causes severe systemic

vasodilation, acute hypotension, reflex tachycardia, coronary ischemia, and cardiac arrest).

  • │
  • ▼ (If Uterine Atony Persists)
  • [ 2. METHYLERGONOVINE (Methergine) - SECOND-LINE ERGOT ALKALOID ]
  • Dose: 0.2 mg IM (or intramyometrial). Repeat q2-4 hours as needed (max 5 doses).
  • Mechanism: Alpha-adrenergic agonist -> sustained, tetanic uterine contractions.

• ABSOLUTE CONTRAINDICATION: HYPERTENSION (Chronic HTN, Gestational HTN, Preeclampsia, eclampsia),

Coronary artery disease, Raynaud's phenomenon. (Risks hypertensive stroke & acute MI).

• Route Warning: NEVER give IV (induces sudden, catastrophic cerebral vasospasm/hypertensive crisis).

  • │
  • ▼ (If Atony Persists or Methergine Contraindicated)
  • [ 3. 15-METHYL PGF2α / CARBOPROST (Hemabate) - SECOND-LINE PROSTAGLANDIN F2α ]
  • Dose: 250 mcg (0.25 mg) IM or deep intramyometrial. Repeat q15-90 min (max 8 doses = 2 mg).
  • Mechanism: Prostaglandin F2α agonist -> powerful myometrial contraction and local vasoconstriction.
  • ABSOLUTE CONTRAINDICATION: ACTIVE ASTHMA / REACTIVE AIRWAY DISEASE, active hepatic or renal disease.

• Common Adverse Effects: Intense bronchospasm, explosive watery diarrhea (give loperamide/diphenoxylate),

nausea, vomiting, significant transient pyrexia (chills/fever up to 102°F/39°C).

  • │
  • ▼ (Adjunctive / Concurrent Administration)
  • [ 4. MISOPROSTOL (Cytotec) - SYNTHETIC PROSTAGLANDIN E1 ]
  • Dose: 800-1,000 mcg Rectally (PR), OR 800 mcg Sublingually (SL), OR 600-800 mcg Orally (PO).
  • Mechanism: PGE1 analog -> increases intracellular calcium -> myometrial smooth muscle contraction.
  • Advantages: Rapid mucosal absorption, stable at room temperature, safe in asthma and hypertension.

• Adverse Effects: Transient shivering/rigors (up to 80% of patients), marked hyperthermia/pyrexia

(can reach 104°F/40°C; distinguish from intra-amniotic infection/sepsis).

  • │
  • ▼ (Administer Within 3 Hours of Birth for Ongoing PPH)
  • [ 5. TRANEXAMIC ACID (TXA) - ANTIFIBRINOLYTIC AGENT ]
  • Dose: 1 g (1,000 mg) in 100 mL NS/D5W IV infused over 10 minutes.

• Timing: MUST be given within 3 hours of birth. If bleeding persists after 30 min or recurs

within 24 hours, administer a second 1 g IV dose.

• Mechanism: Synthetic lysine derivative; reversibly binds plasminogen, blocking its conversion

to plasmin and preventing fibrin clot degradation (stabilizes hemostatic plugs).

• Evidence: WOMAN Trial demonstrated significant reduction in maternal mortality without increasing VTE.

Pharmacologic Summary Comparison Matrix

Medication Typical Dose & Route Onset / Duration Absolute Contraindications Notable Nursing Considerations & Side Effects

Oxytocin (Pitocin) 10–40 units/1,000 mL IV infusion; 10 units IM Immediate (IV); 3–5 min (IM) / 1 hr None in postpartum setting Avoid rapid IV bolus. High doses with electrolyte-free fluid can cause water intoxication/hyponatremia due to ADH-like structure.

Methylergonovine (Methergine) 0.2 mg IM q2–4h (max 5 doses) 2–5 min / 3 hours Hypertension , Preeclampsia, Cardiovascular disease, Raynaud's Assess BP before administration; hold if BP ≥140/90 mmHg. Never administer IV. Keep refrigerated.

15-methyl PGF2α (Carboprost / Hemabate) 250 mcg (0.25 mg) IM q15–90 min (max 8 doses = 2 mg) 15–30 min / 2–4 hours Active Asthma , Reactive Airway Disease, Active Hepatic/Renal Disease Causes severe bronchospasm, violent diarrhea, vomiting, flushing, and transient fever. Pre-medicate with antiemetics/antidiarrheals.

Misoprostol (Cytotec) 800–1,000 mcg PR, 800 mcg SL, or 600–800 mcg PO 15–30 min / 3–4 hours Known allergy to prostaglandins Safe in asthma and hypertension. Causes dramatic shivering/rigors and temperature spike (reassure patient).

Tranexamic Acid (TXA) 1 g in 100 mL IV over 10 min (repeat x1 in 30 min if needed) Immediate / 3 hours Active thromboembolic disease (relative in acute PPH), hypersensitivity Must be initiated within 3 hours of birth. Administer over full 10 minutes to prevent transient hypotension.

Mechanical, Intrauterine & Surgical Tamponade

When pharmacotherapy fails to control bleeding within 10 to 15 minutes, immediate mechanical and surgical interventions must be deployed to arrest hemorrhage before profound coagulopathy develops. +---------------------------------------------------------------------------------------------------+

  • | MECHANICAL & PROCEDURAL PPH ESCALATION PATHWAY |
  • +---------------------------------------------------------------------------------------------------+

[ STEP 1: BIMANUAL UTERINE COMPRESSION ]

  • Insert gloved fist into the anterior vaginal fornix, pushing anterior uterine wall upward.

• Place other hand on maternal abdominal wall behind the fundus, compressing the posterior

uterine wall against the internal fist. Compresses myometrium and spiral arteries directly.

  • │
  • ▼ (If Bleeding Persists)
  • [ STEP 2: INTRAUTERINE BALLOON TAMPONADE (Bakri Balloon) OR SUCTION DEVICE (Jada) ]
  • BAKRI BALLOON: Insert catheter through cervix into uterine cavity under ultrasound guidance;
  • inflate balloon with 300-500 mL sterile saline; connect drainage port; place vaginal pack;

"Tamponade Test": if drainage stops, test is positive (maintain for 12-24 hours).

• JADA VACUUM DEVICE: Low-level intrauterine suction (-80 mmHg) collapses uterine walls onto

themselves, stimulating physiologic myometrial constriction and rapidly evacuating blood.

  • │
  • ▼ (If Refractory Bleeding / Surgical Environment)
  • [ STEP 3: SURGICAL ESCALATION / LAPAROTOMY ]
  • Uterine Compression Sutures: B-Lynch or Hayman vertical brace sutures to mechanically cinch uterus.

• Pelvic Arterial Ligation: Bilateral uterine artery ligation (O'Leary stitches) or hypogastric

(internal iliac) artery ligation.

• Uterine Artery Embolization (UAE): Interventional radiology fluoroscopic coil/gelfoam embolization

(if hemodynamically stable in specialized hybrid suite).

• Peripartum Hysterectomy: Supracervical or total abdominal hysterectomy (definitive life-saving rescue).

Massive Transfusion Protocol (MTP) & Resuscitation Bundle

Severe PPH rapidly transitions from localized bleeding to lethal trauma-induced coagulopathy of pregnancy , driven by the lethal triad : hypothermia (<35°C), progressive metabolic acidosis (pH <7.20, base deficit ≥6 mEq/L), and dilutional/consumptive coagulopathy. +---------------------------------------------------------------------------------------------------+

  • | OBSTETRIC MASSIVE TRANSFUSION PROTOCOL (MTP) |
  • +---------------------------------------------------------------------------------------------------+

[ MTP ACTIVATION CRITERIA ]

  • Cumulative QBL >1,500 mL with active ongoing bleeding.
  • Persistent maternal hemodynamic instability (Shock Index = HR / SBP >=1.0).
  • Transfusion of >4 units PRBCs within 1 hour with anticipated ongoing need.
  • Clinical or laboratory evidence of severe consumptive coagulopathy (DIC, oozing IV sites).
  • │
  • ▼
  • [ BALANCED TRANSFUSION: 1:1:1 RATIO ]
  • 4 to 6 Units Packed Red Blood Cells (PRBCs) - Uncrossed O-Negative (or Type-Specific)
  • 4 to 6 Units Fresh Frozen Plasma (FFP) - Restores clotting factors and volume
  • 1 Adult Dose (Apheretic Unit = 6-pack equivalent) Platelets - Restores platelet count >50,000/mcL
  • │
  • ▼
  • [ TARGETED COAGULATION & BIOCHEMICAL GOALS ]
  • Fibrinogen >=200 mg/dL: Infuse Cryoprecipitate (10-20 units) or Fibrinogen Concentrate if <200 mg/dL.
  • Platelet Count >=50,000/mcL (>=100,000/mcL if active surgical DIC/intracranial concerns).
  • Hematocrit >=24-28% / Hemoglobin >=8 g/dL.
  • PT / PTT <=1.5 times control value / INR <=1.5.
  • Ionized Calcium >=1.1-1.3 mmol/L (Calcium gluconate 1-2 g IV for citrate toxicity from PRBCs).
  • Core Body Temperature >=36.0°C (Use rapid fluid warmers, Bair Hugger forced-air warming).

The Obstetric Shock Index (SI)

Calculation: Shock Index = Maternal Heart Rate (bpm) Systolic Blood Pressure (mmHg) \text{Shock Index} = \frac{\text{Maternal Heart Rate (bpm)}}{\text{Systolic Blood Pressure (mmHg)}} Shock Index = Systolic Blood Pressure (mmHg) Maternal Heart Rate (bpm) ​

Normal Range: 0.5 to 0.7

Clinical Significance: An elevated Shock Index ≥0.9 to 1.0 is an exceptionally sensitive, early predictor of severe maternal hemorrhage, impending hemodynamic collapse, and the need for massive blood transfusion, alerting clinicians long before traditional blood pressure thresholds decline.

Loading diagram... Postpartum Hemorrhage Stepwise Escalation Algorithm